Press release
Ventilator-associated pneumonia (VAP) Market 2018 - Major Players are Merck & Co., Inc. (US), Adenium Biotech ApS (Denmark) and more.
Ventilator-associated pneumonia Market Report is added on Marketresearchfuture.com with 80 pages. The reports also covers brief analysis of Market Structure, Assumptions & Limitations, Research Process, Opportunities, and Porter’s Five Forces Model, Global Ventilator-associated pneumonia Market (By Indications, Type, Application, and Regions), Company Landscape, Company Profile and Worldwide Forecast to 2022Global Ventilator-associated pneumonia (VAP) market has been segmented on the basis of diagnosis which includes clinical, radiological, and microbiological and others. On the basis of end users which consists of hospitals, clinics, research facilities and others. On the basis of mode of treatment home care, hospital care and others.
Get Sample copy of Ventilator-associated pneumonia Market Report@ https://www.marketresearchfuture.com/sample_request/1377 .
Key Players for Ventilator-associated pneumonia (VAP) Market:
Some of the key players in this market are: Merck & Co., Inc. (US), Adenium Biotech ApS (Denmark), AstraZeneca (UK), MedImmune (US), Nabriva Therapeutics AG (Austria).
Global Ventilator-associated Pneumonia (VAP) Market - Overview
Patients in critical care require aid for respiration. Many of them suffer from disease like heart disease which require continuous monitoring by healthcare staff in intensive care unit. Ventilator- associated pneumonia is prevalent among patients admitted to ICUs. It is a significant cause of morbidity and mortality in ICU. This disease results from contaminated pathogen secretions in the lungs. Prolonged use of ventilators in ICU favour the growth of this market. Increase in hospital acquired infection is also another factor contributing for the growth of this market. Prevention of ventilator-associated pneumonia is important to protect the health of patients suffering from life threating diseases.
Get Discount on Ventilator-associated pneumonia Market Report @ https://www.marketresearchfuture.com/check-discount/1377 .
Global Ventilator-associated pneumonia (VAP) market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Global Ventilator-associated Pneumonia (VAP) Market - Competitive Analysis
June, 2016 - AstraZeneca had announced that the European Commission (EC) has granted marketing authorisation for Zavicefta, which a combination antibiotic for the treatment of patients with serious Gram-negative bacterial infections requiring hospitalisation. AstraZeneca is a global, innovation-driven biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas which are respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology and infection and neuroscience. Company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. As per company reports, hospital-acquired pneumonia (HAP) denotes the development of lung infections after a patient has been hospitalised for a minimum of 48 hours.
Global Ventilator-associated pneumonia (VAP) Market - Regional Analysis
Globally, Ventilator-associated pneumonia (VAP) market consists of four regions Americas, Europe, Asia Pacific and Middle East & Africa. America is the largest market for Ventilator-associated pneumonia (VAP) whose growth is contributed to increase in prevalence of smoking leading to lung diseases, large number of patients suffering from chronic heart diseases and demand of mechanical ventilators. The market is growing continuously in Europe due to extensive demand of medical devices in hospitals, and increasing healthcare expenditure. Asia Pacific is expected to be the fastest growing market owing to increase in environmental pollution, high incidence of asthma & chronic obstructive pulmonary disease and large patient pool. Moreover, Awareness regarding prevention of hospital acquired infection, pneumonia and quality control measures taken by hospitals for control of nosocomial infection favour the growth of this market. Increasing ageing population and incidence of infectious disease too contribute for the growth of this market in Asia Pacific. On the other hand, the Middle East & Africa region are likely to have a limited but steady growth in the market.
Browse Complete Report and in-depth TOC @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ventilator-associated pneumonia (VAP) Market 2018 - Major Players are Merck & Co., Inc. (US), Adenium Biotech ApS (Denmark) and more. here
News-ID: 963752 • Views: …
More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035.
Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial…

Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035.
Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are…

Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034.
Cheese packaging…

Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by…
More Releases for VAP
VAP Group to host Singapore Innovation Week
Singapore, 29th September 2025, ZEX PR WIRE, VAP Group is geared to host 17 exclusive side events in Singapore on September 29 2025. The city will turn into a global stage for some of the most prominent voices in Artificial Intelligence (AI), Blockchain, Web3, Gaming, Marketing, and Venture Capital. These events are not just events, instead, they are opportunities to exchange knowledge, spark collaboration, and shape what comes next in…
Ventilator Associated Pneumonia (VAP) Market Demonstrates Robust Growth Potentia …
New Jersey, US State: "The global Ventilator Associated Pneumonia (VAP) market in the Healthcare and Pharmaceuticals category is projected to reach USD 4.1 billion by 2031, growing at a CAGR of 6.5% from 2025 to 2031. With rising industrial adoption and continuous innovation in Healthcare and Pharmaceuticals applications, the market is estimated to hit USD 2.5 billion in 2024, highlighting strong growth potential throughout the forecast period."
Ventilator Associated Pneumonia (VAP)…
Ventilator-associated Pneumonia (VAP) Market: Increase in Hospital Acquired in I …
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Ventilator Associated Pneumonia (VAP) Market size, Share, Growth & Forecast 2026
Ventilator Associated Pneumonia (VAP) Market Overview: 2026
This report focuses on the global Ventilator Associated Pneumonia (VAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ventilator Associated Pneumonia (VAP) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Inquire For Sample: https://reports.valuates.com/request/sample/QYRE-Auto-10Z1992/Global_Ventilator_Associated_Pneumonia_VAP_Market
The key players covered in this study
Philips Respironics
Hoffrichter
…
Ventilator Associated Pneumonia (VAP) Therapeutics Market: Industry Size, Share, …
Ventilator Associated Pneumonia (VAP) Therapeutics Market 2020-2025 Industry research report covers the market landscape and its growth prospects over the coming years, the report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market.
Get Sample Copy of this Report…
Ventilator-associated Pneumonia (VAP) Market is Trending with Major Key Leaders …
An extensive analysis of the “Global Ventilator-associated pneumonia (VAP) market “strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company profiling and a comprehensive review about the strategy concept and the tools that can be used to assess and analyze strategy.
Global Ventilator-associated Pneumonia (VAP) Market - Overview
Patients in critical care…